BKGI Stock Overview
Bangkok Genomics Innovation Public Company Limited provides clinical and genomics services in Thailand.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bangkok Genomics Innovation Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿3.20 |
| 52 Week High | ฿5.65 |
| 52 Week Low | ฿2.14 |
| Beta | 0 |
| 1 Month Change | -5.33% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.27% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BKGI | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 11.1% | 2.9% | 0.9% |
| 1Y | n/a | -6.5% | -11.0% |
Return vs Industry: Insufficient data to determine how BKGI performed against the TH Healthcare industry.
Return vs Market: Insufficient data to determine how BKGI performed against the TH Market.
Price Volatility
| BKGI volatility | |
|---|---|
| BKGI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in TH Market | 9.1% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: BKGI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BKGI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | n/a | www.bangkokgenomics.com |
Bangkok Genomics Innovation Public Company Limited provides clinical and genomics services in Thailand. The company offers non-invasive prenatal testing which includes screening for fetal chromosomal abnormalities under the NIFTY brand; and genetic disease carrier screening testing services, such as screening before embryo implantation, carriers of genetic disease, and detection of gene abnormalities associated with thalassemia anemia under the VISTA brand. It also provides real time-PCR test for COVID-19, antigen testing of the COVID-19, SARS-CoV-2 serology testing, SARS-CoV-2 neutralizing antibody testing, and real time-PCR for monkeypox virus testing, as well as HPV DNA test; colon cancer testing under the COLOTECH brand; and individual genetic testing services under the DNALL brand.
Bangkok Genomics Innovation Public Company Limited Fundamentals Summary
| BKGI fundamental statistics | |
|---|---|
| Market cap | ฿1.92b |
| Earnings (TTM) | ฿32.14m |
| Revenue (TTM) | ฿245.39m |
59.7x
P/E Ratio7.8x
P/S RatioIs BKGI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BKGI income statement (TTM) | |
|---|---|
| Revenue | ฿245.39m |
| Cost of Revenue | ฿129.29m |
| Gross Profit | ฿116.10m |
| Other Expenses | ฿83.96m |
| Earnings | ฿32.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.054 |
| Gross Margin | 47.31% |
| Net Profit Margin | 13.10% |
| Debt/Equity Ratio | 0% |
How did BKGI perform over the long term?
See historical performance and comparison